{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:28:49Z","timestamp":1780446529005,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Telethon Italy"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jaip.2020.06.065","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T21:41:26Z","timestamp":1595281286000},"page":"3535-3542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-1704","authenticated-orcid":false,"given":"Maurizio","family":"Miano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Madeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Stroppiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ven\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack J.H.","family":"Bleesing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Di Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.06.065_bib1","series-title":"GeneReviews\u00ae","article-title":"Gaucherdisease","author":"Pastores","year":"1993"},{"key":"10.1016\/j.jaip.2020.06.065_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10245330500067181","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.jaip.2020.06.065_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.06.065_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2014-12-617514","article-title":"NKT-dependent B-cell activation in Gaucher disease","volume":"125","author":"Salio","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.06.065_bib5","doi-asserted-by":"crossref","first-page":"e0168135","DOI":"10.1371\/journal.pone.0168135","article-title":"Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with Gaucher disease","volume":"11","author":"Limgala","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2020.06.065_bib6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.06.065_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3324\/haematol.12379","article-title":"A\u00a0new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease","volume":"93","author":"Di Rocco","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2020.06.065_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/clim.2001.5069","article-title":"TcR-alpha\/beta(+) CD4(\u2212)CD8(\u2212) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis","volume":"100","author":"Bleesing","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2020.06.065_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2141.2003.04034.x","article-title":"Common expression of an unusual CD45 isoform on T cells from patients with large granular lymphocyte leukaemia and autoimmune lymphoproliferative syndrome","volume":"120","author":"Bleesing","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2020.06.065_bib10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0031-3955(05)70272-8","article-title":"Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival","volume":"47","author":"Bleesing","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaip.2020.06.065_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpeds.2005.09.025","article-title":"Sorting out the causes of ALPS","volume":"147","author":"Bleesing","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2020.06.065_bib12","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood.V98.8.2466","article-title":"Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome","volume":"98","author":"Bleesing","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.06.065_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2015.05.051","article-title":"A\u00a0conserved circular network of coregulated lipids modulates innate immune responses","volume":"162","author":"K\u00f6berlin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2020.06.065_bib14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.06.065_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaip.2020.06.065_bib16","doi-asserted-by":"crossref","first-page":"19530","DOI":"10.1074\/jbc.271.32.19530","article-title":"Accumulation of glucosylceramides in multidrug-resistant cancer cells","volume":"271","author":"Lavie","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2020.06.065_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaip.2020.06.065_bib18","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bbalip.2013.12.013","article-title":"Evolving concepts in cancer therapy through targeting sphingolipid metabolism","volume":"1841","author":"Truman","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaip.2020.06.065_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcmd.2018.04.001","article-title":"Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1","volume":"71","author":"Mistry","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jaip.2020.06.065_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0002-9343(84)90124-4","article-title":"Immune thrombocytopenia and Gaucher's disease","volume":"77","author":"Lester","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2020.06.065_bib21","doi-asserted-by":"crossref","first-page":"e0039","DOI":"10.5041\/RMMJ.10173","article-title":"Hemorrhagic aspects of Gaucher disease","volume":"5","author":"Rosenbaum","year":"2014","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.jaip.2020.06.065_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjh.16098","article-title":"FAS-mediated apoptosis impairment in patients with ALPS\/ALPS-like phenotype carrying variants on CASP10 gene","volume":"187","author":"Miano","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2020.06.065_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/bjh.15178","article-title":"Clinical features and therapeutic challenges of cytopenias belonging to alps and alps-related (ARS) phenotype","volume":"184","author":"Palmisani","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2020.06.065_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.06.065_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bjh.13866","article-title":"How I manage Evans syndrome and AIHA cases in children","volume":"172","author":"Miano","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2020.06.065_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what\u2019s in a name?","volume":"4","author":"Godfrey","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2020.06.065_bib27","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/ijms20061511","article-title":"Therapeutic targeting steroid resistant pro-Inflammatory NK and NKT-like cells in chronic inflammatory lung disease","volume":"20","author":"Hodge","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820307108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820307108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:25:02Z","timestamp":1761974702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820307108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2213219820307108"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.06.065","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defective FAS-Mediated Apoptosis and Immune Dysregulation in Gaucher Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.06.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}